Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | LDHB | P07195 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22388686 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL31134456 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL31482274 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL30296836 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL27505771 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL31028137 | 1.00 | TSHR (0.50) | TSHRPDE4ACYP2C9TP53ACHE | |
| Mucic Acid SCHEMBL28751233 | 0.88 | TSHR (0.56) | TSHRPDE4ACYP2C9TP53ACHE | |
| Mucic Acid SCHEMBL27487755 | 0.88 | TSHR (0.56) | TSHRPDE4ACYP2C9TP53ACHE | |
| SCHEMBL18902784 | 0.87 | PGD (0.37) | TSHRPDE4AACHEALDH1A1PGD | |
| SCHEMBL6686437 | 0.87 | PGD (0.37) | TSHRPDE4AACHEALDH1A1PGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0994111-B1 | TETRAHYDROFURAN DERIVATIVES | TAKARA SHUZO CO (JP) | 2003-06-04 | — | — | EP | claimed |
| US-20250222044-A1 | LIMOSILACTOBACILLUS REUTERI GOLDGUT-LR99 AND APPLICATION THEREOF | Shenzhen Porshealth Bioengineering Co., Ltd. (CN) | 2025-07-10 | — | — | US | disclosed |
| WO-2025034923-A1 | METHODS AND COMPOSITIONS FOR THE PROUDCTION OF AMIDES FROM SUGAR LACTONES | SOLUGEN, INC. (US) | 2025-02-13 | — | — | WO | disclosed |
| CN-116710470-A | Synthesis method | 埃克斯利亚制药有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-115219626-A | Analysis method of dalbavancin synthesis reaction | 丽珠集团福州福兴医药有限公司 | 2022-10-21 | — | — | CN | disclosed |
| US-20170275569-A1 | HAND DISHWASHING DETERGENT HAVING AN IMPROVED EFFECT AGAINST STARCH | HENKEL AG & CO. KGAA (DE) | 2017-09-28 | — | — | US | disclosed |
| US-8329631-B2 | Hand dishwashing detergent | HENKEL AG & CO. KGAA (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20080145892-A1 | Genes and Proteins For the Biosynthesis of the Glycopeptide Antibiotic A40926 | PFIZER (US) | 2008-06-19 | — | — | US | disclosed |
| EP-1578972-A2 | GENES AND PROTEINS FOR THE BIOSYNTHESIS OF THE GLYCOPEPTIDE ANTIBIOTIC A40926 | Vicuron Pharmaceuticals, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004038025-A2 | GENES AND PROTEINS FOR THE BIOSYNTHESIS OF THE GLYCOPEPTIDE ANTIBIOTIC A40926 | VICURON PHARMACEUTICALS INC. (US) | 2004-05-06 | — | — | WO | disclosed |
| EP-0994111-B1 | TETRAHYDROFURAN DERIVATIVES | TAKARA SHUZO CO (JP) | 2003-06-04 | — | — | EP | disclosed |
| US-6133238-A | ANTICANCER ACTION | TAKARA SHUZO CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| EP-0994111-A1 | TETRAHYDROFURAN DERIVATIVES | TAKARA SHUZO CO. LTD. (JP) | 2000-04-19 | — | — | EP | disclosed |
| EP-0824538-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1998-02-25 | — | — | EP | disclosed |
| CN-1036654-C | Amide derivatives of antibiotic A 40926 | LEPETIT SPA (IT) | 1997-12-10 | — | — | CN | disclosed |
| WO-1996035700-A9 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | — | 1997-02-13 | — | — | WO | disclosed |
| WO-1996035700-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1996-11-14 | — | — | WO | disclosed |
| CN-1088932-A | The amide derivative of antibiotic A 40926 | LEPETIT SPA (IT) | 1994-07-06 | — | — | CN | disclosed |
| US-4694069-A | ANTIBIOTICS | SMITHKLINE BECKMAN CORPORATION (US) | 1987-09-15 | — | — | US | disclosed |
| EP-0218416-A2 | Kibdelosporangium aridum SK&F-AAD-609 | SMITHKLINE BEECHAM CORPORATION (US) | 1987-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080145892-A1 | Genes and Proteins For the Biosynthesis of the Glycopeptide Antibiotic A40926 | GALNT6, GALNT13, O60361 | TSHR 2663/4885PDE4A 3641/4885CYP2C9 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.